Endothelial survival factors as targets for antineoplastic therapy. [electronic resource]
Producer: 20020320Description: S109-19 p. digitalISSN:- 1528-9117
- Angiogenesis Inhibitors -- therapeutic use
- Angiopoietin-1
- Animals
- Antineoplastic Agents -- therapeutic use
- Cell Survival
- Endothelial Growth Factors -- antagonists & inhibitors
- Endothelium, Vascular -- drug effects
- Enzyme Inhibitors -- therapeutic use
- Humans
- Indoles -- therapeutic use
- Integrins -- metabolism
- Lymphokines -- antagonists & inhibitors
- Membrane Glycoproteins -- therapeutic use
- Neoplasms -- blood supply
- Neovascularization, Pathologic -- prevention & control
- Oxindoles
- Pericytes -- metabolism
- Propionates
- Pyrroles -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptor, TIE-2
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.